Description
PRINCIPIO ACTIVO: SULBUTIAMINA
Sin enjuaga
MIRCERA® 50 mcg / 0
5 MGFORMA FARMACÉUTICA: 28 SOBRES POLVO GRANULADOPRESENTACIÓN: 1 CAJA
perforación gastrointestinal reciente o antecedentes de úlcera
NALIXONE 500/50 TAB. MG. CAJA C/20 MEDICINALAKESIDE PHARMA PRINCIPIO ACTIVO: SULBUTIAMINASUSTANCIA: NALIXONE TAB. 500 50 MG. CAJA C 20 FABRICANTE: SONS
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
